PMC:7787218 / 19319-19609
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"305","span":{"begin":215,"end":220},"obj":"Gene"},{"id":"312","span":{"begin":41,"end":51},"obj":"Species"}],"attributes":[{"id":"A305","pred":"tao:has_database_id","subj":"305","obj":"Gene:43740568"},{"id":"A312","pred":"tao:has_database_id","subj":"312","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Protein subunit Full-length recombinant SARS-CoV-2 glycoprotein nanoparticle with Matrix M adjuvant\nSpike prefusion protein Novavax Two doses (day 0, day 21)\nIntramuscular Phase 3 Matrix M1 adjuvantFull-length spike protein formulated in polysorbate 80 detergent and Matrix M1 adjuvant"}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T87","span":{"begin":0,"end":100},"obj":"Sentence"},{"id":"T88","span":{"begin":101,"end":160},"obj":"Sentence"},{"id":"T89","span":{"begin":161,"end":290},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Protein subunit Full-length recombinant SARS-CoV-2 glycoprotein nanoparticle with Matrix M adjuvant\nSpike prefusion protein Novavax Two doses (day 0, day 21)\nIntramuscular Phase 3 Matrix M1 adjuvantFull-length spike protein formulated in polysorbate 80 detergent and Matrix M1 adjuvant"}